Merit Medical Reports Results for Quarter Ended June 30, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Merit Medical Systems, Inc. (MMSI) PT Raised to $83 at Needham & Company
July 30, 2021 6:39 AM EDTNeedham & Company analyst Mike Matson raised the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $83.00 (from $73.00) while maintaining a Buy rating.
The analyst commented, "MMSI's 2Q21 revenue and EPS beat consensus. Organic revenue growth improved to 29.3% in 2Q21 from 0.6%... More
Merit Medical Systems Inc. (MMSI) Tops Q2 EPS by 18c; Raises Outlook
July 29, 2021 4:24 PM EDTMerit Medical Systems Inc. (NASDAQ: MMSI) reported Q2 EPS of $0.62, $0.18 better than the analyst estimate of $0.44. Revenue for the quarter came in at $280.3 million versus the consensus estimate of $249.4 million.
GUIDANCE:
Merit Medical Systems Inc. sees FY2021 EPS of... More
